Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

• Status: Completed
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Cooper Health System
• Treatments: Bisacodyl

Criteria

Inclusion Criteria:

• Obstetrical and gynecological patients undergoing abdominal surgery.

Exclusion Criteria:

• Subjects undergoing a bowel resection.

• Subjects who have a nasogastric tube for bowel decompression.

• Subjects allergic to Bisacodyl.

• Subjects with mechanical bowel obstruction undergoing bowel resection.